| Announce Date | 12/04/2025 |
| EPS Normalized Actual | $0 (Beat by $0.11) |
| EPS GAAP Actual | $0 (Beat by $0.11) |
| Revenue Actual | $0.2469B |
| Revenue Surprise | Beat by $246.9M |
| Announce Date | 12/31/1969 (Pre-Market) |
| EPS Normalized Estimate | $ |
| EPS GAAP Estimate | $ |
| Revenue Estimate | $0B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Apr 2027 | 0.32667 | 27.83 | 0.32502 | 0.32795 | 1 |
| Apr 2027 | 1.89 | 4.81 | 1.84075 | 1.93791 | 0 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ4 2025 (Nov 2025) | -0.28 | -0.28 | 0.2469B | -18.51% | 246.9M |
| FQ3 2025 (Aug 2025) | -0.29 | -0.29 | 0.2405B | -7.48% | 240.5M |
| FQ2 2025 (May 2025) | -0.8 | -0.8 | 0.2571B | -7.86% | 257.1M |
| FQ1 2025 (Feb 2025) | -0.41 | -0.41 | 0.2399B | -8.17% | 239.9M |
| FQ4 2024 (Nov 2024) | -0.05 | -0.05 | 0.2926B | 1.57% | 292.6M |
| FQ3 2024 (Jul 2024) | -0.52 | -0.52 | 0.2585B | -12.07% | 258.5M |
| FQ2 2024 (Apr 2024) | -1.63 | -1.63 | 0.2773B | -8.62% | 277.3M |
| FQ1 2024 (Jan 2024) | -0.33 | -0.33 | 0.2595B | -7.94% | 259.5M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ2 2027 (May 2027) | 0.28 | -- | 0.26232 | 0.29768 | 1 |
| FQ1 2027 (Feb 2027) | 0.09 | -- | 0.08431602 | 0.09568398 | 1 |
| FQ4 2026 (Nov 2026) | 0.21 | 233.33 | 0.19674 | 0.22326 | 1 |
| FQ3 2026 (Aug 2026) | 0.07 | 514.29 | 0.06557913 | 0.07442087 | 1 |
| FQ2 2026 (Apr 2026) | 0.2124 | 476.65 | 0.20511 | 0.22278 | 0 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ2 2027 (May 2027) | 0.28B | -- | 0.26B | 0.29B | 1 |
| FQ1 2027 (Feb 2027) | 0.26B | -- | 0.25B | 0.27B | 1 |
| FQ4 2026 (Nov 2026) | 0.28B | 12.89 | 0.27B | 0.3B | 1 |
| FQ3 2026 (Aug 2026) | 0.26B | 5.83 | 0.24B | 0.27B | 1 |
| FQ2 2026 (Apr 2026) | 0.28B | 8.67 | 0.27B | 0.29B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
0
EPS # of Misses
8
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Nov 2025) | -0.28 | -0.28 | 100% | |
| FQ3 2025 (Aug 2025) | -0.29 | -0.29 | 100% | |
| FQ2 2025 (May 2025) | -0.8 | -0.8 | 100% | |
| FQ1 2025 (Feb 2025) | -0.41 | -0.41 | 100% | |
| FQ4 2024 (Nov 2024) | -0.05 | -0.05 | 100% | |
| FQ3 2024 (Jul 2024) | -0.52 | -0.52 | 100% | |
| FQ2 2024 (Apr 2024) | -1.63 | -1.63 | 100% | |
| FQ1 2024 (Jan 2024) | -0.33 | -0.33 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Nov 2025) | $0B | $0.25B | $246.9M | 100% |
| FQ3 2025 (Aug 2025) | $0B | $0.24B | $240.5M | 100% |
| FQ2 2025 (May 2025) | $0B | $0.26B | $257.1M | 100% |
| FQ1 2025 (Feb 2025) | $0B | $0.24B | $239.9M | 100% |
| FQ4 2024 (Nov 2024) | $0B | $0.29B | $292.6M | 100% |
| FQ3 2024 (Jul 2024) | $0B | $0.26B | $258.5M | 100% |
| FQ2 2024 (Apr 2024) | $0B | $0.28B | $277.3M | 100% |
| FQ1 2024 (Jan 2024) | $0B | $0.26B | $259.5M | 100% |